A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor
References (33)
- et al.
Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo
European J. Pharmacol.
(1986) - et al.
Pharmacological effects of a specific dopamine D-1 antagonist SCH23390 in comparison with neuroleptics
Life Sci.
(1984) - et al.
Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566
Life Sci.
(1986) - et al.
[125I]SCH 23982, a ‘selective’ D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus
European J. Pharmacol.
(1988) SCH23390 - the first selective dopamine D-1 antagonist
European J. Pharmacol.
(1983)- et al.
Catalepsy induced by SCH 23390 in rats
European J. Pharmacol.
(1985) - et al.
An iodinated ligand identifying the D-1 dopamine receptor
European J. Pharmacol.
(1985) - et al.
[125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor
European J. Pharmacol.
(1986) Behavioral correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SK&F 83566, and functionally interactive D-1:D-2 receptor systems
Biochem. Pharmacol.
(1986)- et al.
Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor
J. Neurochem.
(1986)
Differential involvement of dopamine D-1 and D-2 receptors in the circling behavior induced by apomorphine, SK&F38393, pergolide and LY171555 in 6-hydroxydopamine-lesioned rats
Psychopharmacology
(1985)
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands
J. Med. Chem.
(1988)
Relationship between the inhibition constant (Ki) and the concentration of the inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction
Biochem. Pharmacol.
(1973)
D1 dopamine receptor - the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
Synapse
(1987)
D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5′-triphosphate
Endocrinology
(1982)
Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases
J. Neural Transm.
(1988)
Cited by (34)
(+)-[<sup>76</sup>Br]A-69024: A non-benzazepine radioligand for studies of dopamine D1 receptors using PET
2002, Nuclear Medicine and BiologyEffects of endogenous neurotransmitters on the in vivo binding of dopamine and 5-HT radiotracers in mice
2001, Neuropsychopharmacology[<sup>11</sup>C]A-69024: A potent and selective non-benzazepine radiotracer for in vivo studies of dopamine D1 receptors
1995, Nuclear Medicine and Biology
Copyright © 1989 Published by Elsevier B.V.